Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact.
作者信息
Ellman Tanya M, Alemayehu Bereket, Abrams Elaine J, Arpadi Stephen, Howard Andrea A, El-Sadr Wafaa M
机构信息
Mailman School of Public Health, ICAP at Columbia University, New York, NY, USA.
Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
出版信息
J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25007.
Abstract
摘要
相似文献
1
Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact.在资源有限的环境中选择用于常规监测的病毒载量阈值：优化个体健康和人群影响。
J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25007.
2
[Optimizing resources to reduce costs to determine HIV viral load in limited resources settings].[优化资源以降低成本，从而在资源有限的环境中确定HIV病毒载量]
Biomedica. 2017 Dec 1;37(4):460-465. doi: 10.7705/biomedica.v37i4.3318.
3
Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.超越一线 HIV 治疗方案：资源有限环境下的抗逆转录病毒治疗方案、病毒载量监测和耐药性检测的现状。
Curr Opin HIV AIDS. 2013 Nov;8(6):586-90. doi: 10.1097/COH.0000000000000004.
4
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?在资源有限的环境中，HIV逆转录酶活性检测能否成为病毒载量监测的低成本替代方法？
BMJ Open. 2016 Jan 27;6(1):e008795. doi: 10.1136/bmjopen-2015-008795.
5
Comparative evaluation of a reverse transcriptase based assay for HIV-1 viral load quantitation in resource limited settings.资源有限环境下用于HIV-1病毒载量定量的基于逆转录酶检测方法的比较评估。
J Virol Methods. 2014 Jul;203:1-4. doi: 10.1016/j.jviromet.2014.02.021. Epub 2014 Mar 23.
6
Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settings.在资源有限环境中用于艾滋病毒诊断和治疗监测的检测方法开发方面的研究需求与挑战。
Curr Opin HIV AIDS. 2008 Jul;3(4):495-503. doi: 10.1097/COH.0b013e328303e5f9.
7
The role of point-of-care viral load monitoring in achieving the target of 90% suppression in HIV-infected patients in Nigeria: study protocol for a randomized controlled trial.尼日利亚实现 90%HIV 感染患者病毒载量抑制目标的即时检测病毒载量监测作用：一项随机对照试验研究方案。
BMC Infect Dis. 2019 May 2;19(1):368. doi: 10.1186/s12879-019-3983-6.
8
Scale-up of Routine Viral Load Testing in Resource-Poor Settings: Current and Future Implementation Challenges.在资源匮乏地区扩大常规病毒载量检测：当前及未来的实施挑战
Clin Infect Dis. 2016 Apr 15;62(8):1043-8. doi: 10.1093/cid/ciw001. Epub 2016 Jan 6.
9
A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy.一种用于筛查南非接受一线抗逆转录病毒治疗患者病毒学失败和抗逆转录病毒药物耐药性的定性PCR微池策略。
J Clin Virol. 2014 Aug;60(4):387-91. doi: 10.1016/j.jcv.2014.05.011. Epub 2014 May 29.
10
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.在资源匮乏地区，与单纯临床监测相比，采用 HIV 病毒载量、CD4 细胞计数监测联合临床评估的方法进行抗逆转录病毒治疗的成本效益分析（Stratall ANRS 12110/ESTHER）
Lancet Infect Dis. 2013 Jul;13(7):577-86. doi: 10.1016/S1473-3099(13)70073-2. Epub 2013 Apr 18.
引用本文的文献
1
Viral load change and time to death among adult HIV/AIDS patients on ART after test-and-treat in Northwest Ethiopia: a retrospective multi-center follow-up study using Bayesian joint modeling.埃塞俄比亚西北部接受检测即治疗的成年艾滋病病毒/艾滋病患者接受抗逆转录病毒治疗后的病毒载量变化及死亡时间：一项使用贝叶斯联合模型的回顾性多中心随访研究
Front Public Health. 2025 Mar 18;13:1418999. doi: 10.3389/fpubh.2025.1418999. eCollection 2025.
2
The urgent need for newer drugs in routine HIV treatment in Africa: the case of Ghana.非洲常规艾滋病病毒治疗中对新型药物的迫切需求：以加纳为例。
Front Epidemiol. 2025 Mar 14;5:1523109. doi: 10.3389/fepid.2025.1523109. eCollection 2025.
3
Comorbidities and HIV-related factors associated with mental health symptoms and unhealthy substance use among older adults living with HIV in low- and middle-income countries: a cross-sectional study.中低收入国家感染艾滋病毒的老年人中与心理健康症状及不健康物质使用相关的合并症和艾滋病毒相关因素：一项横断面研究
J Int AIDS Soc. 2025 Mar;28(3):e26434. doi: 10.1002/jia2.26434.
4
Prevention of adverse HIV treatment outcomes: machine learning to enable proactive support of people at risk of HIV care disengagement in Tanzania.预防不良的 HIV 治疗结局：机器学习可支持坦桑尼亚面临 HIV 护理脱失风险人群的主动支持。
BMJ Open. 2024 Sep 24;14(9):e088782. doi: 10.1136/bmjopen-2024-088782.
5
The rollout of paediatric dolutegravir and virological outcomes among children living with HIV in Mozambique.莫桑比克感染艾滋病毒儿童中儿科多替拉韦的推广及病毒学结果
South Afr J HIV Med. 2024 Jul 31;25(1):1578. doi: 10.4102/sajhivmed.v25i1.1578. eCollection 2024.
6
Field study to determine the reliability of HIV viral load results shows minimal impact of delayed testing in South Africa.确定艾滋病毒病毒载量结果可靠性的实地研究表明，在南非，延迟检测的影响微乎其微。
Afr J Lab Med. 2024 May 28;13(1):2364. doi: 10.4102/ajlm.v13i1.2364. eCollection 2024.
7
Incidence of Health Facility Switching and Associations With HIV Viral Rebound Among Persons on Antiretroviral Therapy in Uganda: A Population-based Study.乌干达接受抗逆转录病毒治疗人群中卫生机构更换的发生率及其与 HIV 病毒反弹的关联：一项基于人群的研究。
Clin Infect Dis. 2024 Jun 14;78(6):1591-1600. doi: 10.1093/cid/ciad773.
8
Tuberculosis testing patterns in South Africa to identify groups that would benefit from increased investigation.南非的结核病检测模式，以确定哪些群体将从增加调查中受益。
Sci Rep. 2023 Nov 27;13(1):20875. doi: 10.1038/s41598-023-47148-y.
9
Using decision analysis for intervention value efficiency to select optimized interventions in the multiphase optimization strategy.利用决策分析进行干预价值效率，在多阶段优化策略中选择优化干预措施。
Health Psychol. 2024 Feb;43(2):89-100. doi: 10.1037/hea0001318. Epub 2023 Aug 3.
10
Estimating potential silent transfer using baseline viral load measures among people presenting as new to HIV care in Lusaka, Zambia: a cross-sectional study.在赞比亚卢萨卡，使用基线病毒载量衡量新进入 HIV 护理人群中的潜在无症状传播：一项横断面研究。
BMJ Open. 2023 May 25;13(5):e070384. doi: 10.1136/bmjopen-2022-070384.
本文引用的文献
1
Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.扩大艾滋病毒病毒载量监测范围的进展情况-撒哈拉以南非洲七个国家，2015 年 1 月至 2016 年 6 月。
MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1332-1335. doi: 10.15585/mmwr.mm6547a2.
2
Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.HIV 病毒载量监测扩大规模——七个撒哈拉以南非洲国家。
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1287-90. doi: 10.15585/mmwr.mm6446a3.
3
4
Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.HIV-1感染患者持续低水平病毒血症和极低水平病毒血症的意义及临床管理
Antimicrob Agents Chemother. 2014 Jul;58(7):3585-98. doi: 10.1128/AAC.00076-14. Epub 2014 Apr 14.
5
Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.在一组 HIV 阳性患者中，持续低水平病毒血症后的病毒学失败：12 年观察结果。
Clin Infect Dis. 2013 Nov;57(10):1489-96. doi: 10.1093/cid/cit529. Epub 2013 Aug 14.
6
Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.基于 CD4 计数与病毒载量监测切换成人 HIV 治疗：泰国的一项随机、非劣效试验。
PLoS Med. 2013 Aug;10(8):e1001494. doi: 10.1371/journal.pmed.1001494. Epub 2013 Aug 6.
7
Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.抗逆转录病毒治疗下 HIV 阳性伴侣病毒完全抑制的异性血清学不一致的夫妇间 HIV 传播的系统评价
PLoS One. 2013;8(2):e55747. doi: 10.1371/journal.pone.0055747. Epub 2013 Feb 13.
8
Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.免疫标准是对病毒学结果的不良预测指标：对资源有限环境下的 HIV 治疗监测的影响。
Clin Infect Dis. 2011 Dec;53(12):1283-90. doi: 10.1093/cid/cir729.
9
10
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy.一线治疗中持续性低病毒载量的 HIV-1 感染患者中的抗逆转录病毒药物耐药性。
J Infect Dis. 2011 Aug 15;204(4):515-20. doi: 10.1093/infdis/jir353.
Zotero 插件